Connection

Thomas Efferth to ErbB Receptors

Back to Details
This is a "connection" page, showing publications Thomas Efferth has written about ErbB Receptors.
Thomas Efferth
Connection Strength
1.067
ErbB Receptors
  1. Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib. Phytomedicine. 2017 Dec 15; 37:58-61.
    View in: PubMed
    Score: 0.590
  2. Broad-spectrum Cross-resistance to Anticancer Drugs Mediated by Epidermal Growth Factor Receptor. Anticancer Res. 2019 Jul; 39(7):3585-3593.
    View in: PubMed
    Score: 0.165
  3. Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression. Phytomedicine. 2019 Jun; 59:152890.
    View in: PubMed
    Score: 0.162
  4. Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells. J Ethnopharmacol. 2018 Apr 06; 215:233-240.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.